References
- Feinstein D.I. Acquired inhibitors against factor VIII and other clotting proteins. Hemostasis and thrombosis. Basic principles and clinical practice, R.W. Colman, J. Hirsh, V.J. Marder, E.W. Salzman. Lippincott, Philadelphia 1987; 825–838
- Hoyer L.W. Factor VIII inhibitors: a continuing problem. J. Lab. Clin. Med. 1993; 121: 385–387
- Green D., Lechner K. A survey of 215 non-haemophilic patients with inhibitors to factor VIII. Thromb. Haemost. 1981; 45: 200–203
- Lin C.K., Liang R., Liu H.W., Tse P.W.T., Chan G.T.C. Myelodysplastic syndrome and acquired factor VIII inhibitor with severe subcutaneous haemorrhage. Acta Haematol 1991; 85: 206–208
- Komminoth A., Dufour P., Bergerat J.P., Wiesel M.L., Falkenrodt A., Oberling F. Hairy cell leukemia and factor VIII inhibitor: a case report. Nouv. Rev. Fr. Hematol. 1992; 34: 269–271
- DeVita V.T., Jr., Hubbard S.M., Longo D.L. Treatment of Hodgkin's disease, y. Natl. Cancer Inst. 1990; 10: 19–28
- Goldsmith J.C. Diagnosis of factor VIII versus nonspecific inhibitors. Semin. Hematol 1993; 30(suppl 1)3–6
- Green D. Immunosuppression of factor VIII inhibitors in nonhemophilic patients. Semin. Hematol 1993; 30(suppl 1)28–31
- Zinzani P.L., Fiacchini M., Mazza P., Gherlinzoni F., Bocchia M., Tura S. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia. Haematologica 1991; 76: 305–310
- Estey E., Plunkett W., Gandhi V., Rios M.B., Kantarjian H.M., Keating M.J. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. Leuk. Lymph. 1993; 9: 343–350
- Zinzani P.L., Lauria F., Rondelli D., Benfenati D., Raspadori D., Bocchia M., Bendandi M., Gozzetti A., Zaja F., Fanin R., Russo D., Galieni P., Tura S. Fludarabine: An active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. Ann. Oncol 1993; 4: 575–578
- Keating M.J., Kantarjian H.M., Talpaz M., Redman J., Roller C., Barlogie B., Velasquez W., Plunkett W., Freireich E.J., McCredie K.B. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25
- Kantarjian H.M., Childs C., O'Brien S., Huh Y., Beran M., Schachner J., Koller C., Keating M.J. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with pro-lymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia. Am. J. Med. 1991; 90: 223–228
- Kantarjian H.M., Alexanian R., Koller C., Kurzrock R., Keating M.J. Fludarabine therapy in macroglobulinemic lymphoma. Blood 1990; 75: 1928–1931